-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
technology and services. Assures satisfaction of patients, physicians and other customers with care and services that are delivered. Develops and fosters collaborative relationships with other departments
-
) to support GMP Manufacturing and analytical development for cellular immunotherapy products. This fast-paced lab focuses on cutting-edge technology, research, and clinical cellular immunotherapeutic programs
-
of the Division of Epigenetics and Transcriptional Engineering at City of Hope Cancer Center. His lab investigates epigenetic mechanisms of drug resistance and identifies therapeutic targets in various
-
policies and procedures. Utilize rounding boards and staff huddles to support organizational goals. Support departmental implementation of new technology and services. Ensure protocol compliance and provide
-
technology, research, and clinical cellular immunotherapy programs, including cell viability, Flow Cytometry, ELISA, qPCR, ddPCR, potency, and cytotoxicity assays. The QCA II will also receive training
-
Associate III (QCA III) to support in-process and release testing for GMP Manufacturing and gene and cellular immunotherapy products. This fast-paced lab uses cutting-edge technology for clinical
-
malignancies using engineered cellular therapies. We are looking for a highly motivated candidate with a PhD and/or MD degree interested in combining novel rational and combinatorial synthetic biology approaches